Profound Medical Corp. (PROF)


+0.09 (+0.90%)
Symbol PROF
Price $10.09
Beta 1.214
Volume Avg. 0.02M
Market Cap 214.519M
Shares () -
52 Week Range 5.26-15.49
1y Target Est -
DCF Unlevered PROF DCF ->
DCF Levered PROF LDCF ->
ROE -63.57% Strong Sell
ROA -57.86% Strong Sell
Operating Margin -
Debt / Equity 21.07% Neutral
P/E -7.26 Strong Sell
P/B 5.60 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest PROF news

Dr. Arun Swarup Menawat MBA, Ph.D.
Medical Devices
NASDAQ Capital Market

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.